Zobrazeno 1 - 10
of 220
pro vyhledávání: '"real-world analysis"'
Autor:
Vogelmeier CF, Beeh KM, Schultze M, Kossack N, Richter LM, Claussen J, Compton C, Noorduyn SG, Ismaila AS, Requena G
Publikováno v:
International Journal of COPD, Vol Volume 19, Pp 1835-1848 (2024)
Claus F Vogelmeier,1 Kai-Michael Beeh,2 Michael Schultze,3 Nils Kossack,4 Lena M Richter,4 Jing Claussen,5 Chris Compton,6 Stephen G Noorduyn,7,8 Afisi S Ismaila,8,9 Gema Requena10 1Department of Medicine, Pulmonary and Critical Care Medicine, Univer
Externí odkaz:
https://doaj.org/article/7bf00fe9cefe48c69896c215b1071c2d
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundPralsetinib, a selective oral inhibitor of rearranged during transfection (RET) fusion proteins and oncogenic RET mutants, has shown significant efficacy in treating RET fusion-positive non-small cell lung cancer and thyroid cancer. However
Externí odkaz:
https://doaj.org/article/b370a1dfd9c8400b88880881b9190b94
Autor:
Yingyong Ou, Zhiwei Cui, Siyu Lou, Chengyu Zhu, Junyou Chen, Linmei Zhou, Ruizhen Zhao, Li Wang, Fan Zou
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
ObjectiveTirzepatide, a novel GIP and GLP1 agonist, has been extensively examined in clinical trials. However, specific data on its adverse drug events (ADEs) remain limited. This study aims to comprehensively assess real-world ADEs associated with t
Externí odkaz:
https://doaj.org/article/7b3c4b8bce424895aaca3791ce84a0ff
Autor:
Paola Stefanoni, Monica Galli, Laura Paris, Alessandro Rambaldi, Nicola Pittalis, Gianluca Cavallaro, Chiara Pavoni
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 16, Iss 1 (2024)
We performed a monocentric, retrospective real-world analysis (RWA) to evaluate the feasibility and the main results of an autologous stem cell transplantation (ASCT)-based program in a cohort of 90 newly diagnosed multiple myeloma patients aged > 65
Externí odkaz:
https://doaj.org/article/388f1920e3554d6c8e62cb8e255dc256
Autor:
Chuanli Yang, Pengyang Xu, Teng Wu, Yunhe Fan, Qingqing Li, Jijun Zhang, Xiaobing Shen, Xiushan Dong
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
BackgroundAprepitant, fosaprepitant, and netupitant are three common neurokinin-1 receptor antagonists (NK-1RAs) used to prevent chemotherapy-induced nausea and vomiting, following highly or moderately emetogenic chemotherapy. Understanding their dif
Externí odkaz:
https://doaj.org/article/8c38cb804a71487999ea9606e14a165d
Publikováno v:
Clinical and Translational Allergy, Vol 14, Iss 7, Pp n/a-n/a (2024)
Abstract Background House dust mite (HDM) sensitisation can contribute to the development of allergic rhinoconjunctivitis (AR) or allergic asthma (AA). As treatment, allergen immunotherapy (AIT) is a promising approach, since it aims building immunot
Externí odkaz:
https://doaj.org/article/a94523784f994973b6043b5fcaa00c08
Publikováno v:
The Journal of Clinical Hypertension, Vol 25, Iss 8, Pp 737-747 (2023)
Abstract Patients with apparent treatment‐resistant hypertension (aTRH) are at increased risk of end‐organ damage and cardiovascular events. Little is known about the effects of blood pressure (BP) control in this population. Using a national cla
Externí odkaz:
https://doaj.org/article/96bae165730146c18e52de0faef8dc5a
Autor:
Fan Zou, Zhiwei Cui, Siyu Lou, Yingyong Ou, Chengyu Zhu, Chengjie Shu, Junyou Chen, Ruizhen Zhao, Zhu Wu, Li Wang, Zhenyong Chen, Huayu Chen, Yuanbo Lan
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Introduction: Linezolid is an oxazolidinone antibiotic that is active against drug-resistant Gram-positive bacteria and multidrug-resistant Mycobacterium tuberculosis. Real-world studies on the safety of linezolid in large populations are lacking. Th
Externí odkaz:
https://doaj.org/article/3381342df8ee457a9ac2d16a17da312b
Autor:
Valentin Barsan, Yimei Li, Snehit Prabhu, Christina Baggott, Khanh Nguyen, Holly Pacenta, Christine L. Phillips, Jenna Rossoff, Heather Stefanski, Julie-An Talano, Amy Moskop, Susanne Baumeister, Michael R. Verneris, Gary Douglas Myers, Nicole A. Karras, Stacy Cooper, Muna Qayed, Michelle Hermiston, Prakash Satwani, Christa Krupski, Amy Keating, Vanessa Fabrizio, Vasant Chinnabhandar, Michael Kunicki, Kevin J. Curran, Crystal L. Mackall, Theodore W. Laetsch, Liora M. Schultz
Publikováno v:
EClinicalMedicine, Vol 65, Iss , Pp 102268- (2023)
Summary: Background: Tisagenlecleucel was approved by the Food and Drug Administration (FDA) in 2017 for refractory B-cell acute lymphoblastic leukemia (B-ALL) and B-ALL in ≥2nd relapse. Outcomes of patients receiving commercial tisagenlecleucel up
Externí odkaz:
https://doaj.org/article/20c0403244324301a828fb1de6d7904b
Publikováno v:
Clinical and Translational Allergy, Vol 13, Iss 5, Pp n/a-n/a (2023)
Abstract Introduction Allergic rhinitis (AR) is a widespread disease with increasing prevalence in developed countries. The only treatment that tackles the underlying causes is allergen immunotherapy (AIT). This treatment is performed through two app
Externí odkaz:
https://doaj.org/article/38c654b92d0c4219b5dd11a7368036b5